Overview Aromasin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer after menopause. Aromasin is used as an adjuvant, or… read more
Your Cookies
In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.